Aquaporin 1 and pulmonary hypertension
水通道蛋白 1 和肺动脉高压
基本信息
- 批准号:10538750
- 负责人:
- 金额:$ 70.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AQP1 geneApoptosisApoptoticBindingBinding SitesBlood VesselsBlood capillariesC-terminalCell AdhesionCell HypoxiaCell NucleusCell ProliferationCell SurvivalCell physiologyCellsComplexDataDevelopmentDiseaseDistalEndothelial CellsEndotheliumEpithelial CellsFailureFamily memberHumanHypoxiaKnowledgeLaboratoriesLesionLungMediatingModelingMolecularMuscleMutateNuclearNuclear TranslocationPathologyPathway interactionsPatientsPermeabilityPhenotypePredispositionPreventionProtein FamilyProteinsPublishingPulmonary HypertensionPulmonary arterial remodelingRattusRegulationReportingRepressionResistanceRoleSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesStimulusTailTestingUp-RegulationVascular remodelingWaterbasebeta catenincell growthcell motilitycytochrome cexperimental studyglycogen synthase kinase 3 betaimprovedin silicoinsightlung microvascular endothelial cellsmigrationmortalitynovelnovel therapeuticspreventprotein functionprotein protein interactionpulmonary arterial hypertensionpulmonary arterial pressurerenal epitheliumresponseright ventricular failuretherapeutic targetwater channel
项目摘要
PROJECT SUMMARY
Pulmonary arterial hypertension (PAH) is a severely debilitating disease with no cure. Morphometric
studies revealed that the development of pulmonary hypertension is associated with robust structural
remodeling of the small pulmonary arteries, characterized by thickening of the endothelial and smooth muscle
cell layers and formation of occlusive lesions. In addition to increased proliferation and migration of vascular
cells, failure of appropriate apoptosis (i.e., apoptotic resistance) contributes to remodeling via lack of cell
turnover. Our laboratory identified a new candidate as a regulator of pulmonary arterial smooth muscle cell
(PASMC) function: aquaporins (AQPs). AQPs are a family of proteins that form transmembrane channels
which facilitate the transport of water into and out of cells. We have evidence that aquaporin 1 (AQP1), the first
family member identified, is expressed in PASMCs and pulmonary microvascular endothelial cells (PMVECs),
upregulated in a rat model of PAH and modulates susceptibility to apoptosis. Our preliminary data also indicate
that increased AQP1 protein is associated with elevated β-catenin expression, a protein that regulates
migratory, proliferative and survival responses. The mechanism by which AQP1 regulates β-catenin levels is
currently unknown; we have generated exciting data indicating a critical role for a specific region of the AQP1
C-terminal tail. This region contains a previously unrecognized putative binding site for GSK3β, an endogenous
regulator of β-catenin abundance. Based on these data, we hypothesize that in PAH PASMCs and PMVECs,
increased AQP1 levels contribute to cell growth and survival by sequestering GSK3β and reducing its
activity/nuclear localization; as a consequence, β-catenin accumulates, promoting migration and proliferation
and preventing apoptosis. The Aims of this study are to: 1) determine whether AQP1 regulates β-catenin via
binding to GSK3β; 2) identify the mechanism by which AQP1 facilitates cell growth and survival; and 3)
evaluate whether cell-specific disruption of AQP1 prevents or reverses PAH.
项目摘要
肺动脉高压(PAH)是一种严重令人衰弱的疾病,无法治愈。形态计量学
研究表明,肺动脉高压的发展与健壮的结构有关
小肺动脉的重塑,其特征是内皮和平滑肌增厚
细胞层和闭塞病变的形成。除了增加血管增殖和迁移
细胞,适当凋亡(即凋亡耐药性)的失败有助于通过缺乏细胞进行重塑
周转。我们的实验室将新候选者确定为肺动脉平滑肌细胞的调节剂
(PASMC)功能:水通道蛋白(AQPS)。 AQP是形成跨膜通道的蛋白质家族
这有助于水进入和流出细胞。我们有证据表明Aquaporin 1(AQP1),第一个
鉴定出的家庭成员在PASMC和肺微血管内皮细胞(PMVEC)中表达,
在大鼠模型中上调,并调节凋亡的易感性。我们的初步数据也表明
增加的AQP1蛋白与β-catenin的表达升高有关,β-catenin表达是调节的蛋白
迁移,增殖和生存反应。 AQP1调节β-catenin水平的机制为
目前未知;我们生成了令人兴奋的数据,表明AQP1特定区域的关键作用
C末端。该区域包含一个以前未被认可的GSK3β的假定结合位点(一种内生
β-catenin丰度。基于这些数据,我们假设在PAH PASMC和PMVEC中,
AQP1水平升高通过隔离GSK3β并减少其生存促进细胞生长和存活
活动/核定位;结果,β-catenin积累,促进迁移和增殖
并防止凋亡。这项研究的目的是:1)确定AQP1是否通过通过
与GSK3β结合; 2)确定AQP1促进细胞生长和存活的机制; 3)
评估AQP1的细胞特异性破坏是否阻止或逆转PAH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Larissa A. Shimoda其他文献
Larissa A. Shimoda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Larissa A. Shimoda', 18)}}的其他基金
Functional linkage of NHE1 and calpain in IPAH
IPAH 中 NHE1 和钙蛋白酶的功能联系
- 批准号:
8354085 - 财政年份:2012
- 资助金额:
$ 70.46万 - 项目类别:
Functional linkage of NHE1 and calpain in IPAH
IPAH 中 NHE1 和钙蛋白酶的功能联系
- 批准号:
8526547 - 财政年份:2012
- 资助金额:
$ 70.46万 - 项目类别:
Interrogation of the Cellular Pathogenesis of Pulmonary Hypertension
肺动脉高压的细胞发病机制的探讨
- 批准号:
8197835 - 财政年份:2011
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
6789297 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
6915721 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pulmonary vascular smooth muscle
慢性缺氧与肺血管平滑肌
- 批准号:
7093559 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic Hypoxia and pH Homeostasis in Pulmonary Myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
8287004 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic Hypoxia and pH Homeostasis in Pulmonary Myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
8505017 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
Chronic hypoxia and pH homeostasis in pulmonary myocytes
肺肌细胞的慢性缺氧和 pH 稳态
- 批准号:
7076849 - 财政年份:2003
- 资助金额:
$ 70.46万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular mechanisms underlying renal lipotoxicity and DKD progression
肾脂毒性和 DKD 进展的分子机制
- 批准号:
10629589 - 财政年份:2023
- 资助金额:
$ 70.46万 - 项目类别:
Mechanisms Driving Apoptosis Resistance in Pulmonary Hypertension
肺动脉高压中细胞凋亡抵抗的驱动机制
- 批准号:
10536247 - 财政年份:2022
- 资助金额:
$ 70.46万 - 项目类别:
Mechanisms Driving Apoptosis Resistance in Pulmonary Hypertension
肺动脉高压中细胞凋亡抵抗的驱动机制
- 批准号:
10843723 - 财政年份:2022
- 资助金额:
$ 70.46万 - 项目类别: